Dr. Michael George Wilkerson, MD

Dr. Wilkerson practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Wilkerson's NPI, 1437217130, was assigned on December 5, 2006. Dr. Wilkerson graduated from McGovern Medical School in 1984. Dr. Wilkerson holds Texas license G9010.

Dr. Wilkerson's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Wilkerson's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Dr. Wilkerson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wilkerson practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Wilkerson's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Wilkerson is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Wilkerson's licenses on file in 2 states: Texas and Oklahoma.

Dmand AI lists acne, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, joint cyst, psoriasis and rash among the conditions Dr. Wilkerson treats.

CMS data shows 2,195 Medicare services from Dr. Wilkerson across 12 procedure codes in 2024, for 373 Medicare patients. Medicare paid $50,725 for them.

CMS counts 373 Medicare patients who saw Dr. Wilkerson in 2024. The largest group is 65 to 74, with 181 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wilkerson's median patient age at 73, with 47% women.

In 2024, Dr. Wilkerson wrote 94 Medicare Part D claims for 45 patients. 89% of them were for generic drugs. CMS names the drug for 26 of them, across 1 drug with 11 or more claims each, at $312 in total drug cost. In 2022, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Wilkerson for performance year 2024, reported as part of a group. Dr. Wilkerson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 551 procedures of removal of skin lesions by Dr. Wilkerson, more than 87% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 67 papers to Dr. Wilkerson, published from 2009 to 2025. 2024 was the busiest year, with 9. The most frequent topics are Skin, Anti-Bacterial Agents and Drug Eruptions. Dr. Wilkerson has published most often in J Am Acad Dermatol. Dr. Wilkerson's most frequent co-authors are Rebecca Catherine Philips, MD, Brent Christopher Kelly, MD and Paige Elizabeth Hoyer, MD.

CMS Open Payments shows 3 general payments to Dr. Wilkerson from 3 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 89% of the total. Pfizer Inc. paid the most, $105.

Dmand AI lists 4 awards for Dr. Wilkerson, most recently CMS Stage 1 EHR in 2013.

Dr. Wilkerson graduated from McGovern Medical School in 1984. Dr. Wilkerson is a member of AAD and ASDS.

Dr. Wilkerson is in network with 22 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.